The most important factor driving the growth of ophthalmology drugs and devices market is the increasing incidences of eye disorders among the aging population. One in every three elderly people is found to have some or other form of eye diseases and the risk of severe eye problems increases significantly with the age, particularly, for those who are in the age group of 60 years and above. It is estimated that the population of the U.S. will grow by 50 million by 2030, thus, adding 4 million patients with dry eyes symptoms. Moreover, according to the studies, women live longer than men and hence, have higher chances of having dry eye diseases. With the increase in the technological innovations, minimally invasive surgery procedures are rapidly replacing open surgeries. The patients are increasingly opting for minimally invasive surgeries owing to the benefits of these procedures which include reduced post-operative recovery time and hospital stays.
Download PDF Brochure @ http://www.micromarketmonitor.com/contact/7535669233-download_pdf_brochure.html
Changing geographical trends across the globe offer significant opportunities for the growth of the North American ophthalmology cataract surgery devices market. Studies have revealed that some diseases, such as, glaucoma are more prevalent in America, and are the leading cause of blindness among Americans. Changing demographics also present considerable opportunities in this market. The increase in the prevalence of lifestyle disorders, such as diabetes caused by the consumption of high calorie diets, is also contributing to the growth of the North American ophthalmology cataract surgery devices market. For instance, diabetic retinopathy that occurs due to diabetes-related changes in the eyes is one of the major causes of vision loss.
Speak to Analyst @ http://www.micromarketmonitor.com/contact/7535669233-speak_to_analyst.html
In-depth profiling of the key players has been conducted along with the recent developments, such as, new product launches, partnerships, agreements, collaborations, and joint ventures. The report also provides detailed information about the strategies adopted by these leading market players to sustain and strengthen their position in the North American ophthalmology cataract surgery devices market. The key players in this market are Abbott Laboratories (U.S.), Alcon, Inc., Allergan, Inc. (U.S.), Bausch & Lomb, Inc. (U.S.), Carl Zeiss Meditech AG (Germany), Essilor International S.A. (France), NIDEK Co., Ltd. (Japan), Topcon Corporation (Japan), and STAAR Surgical Company (U.S.), among others.
